Home / Blood Glucose Control (page 14)

Blood Glucose Control

AI‑First Clinics: What Happens When Algorithms Drive Most of the Diabetes Visit?

A doctor and patient discussing diabetes care with a futuristic AI dashboard displaying CGM and treatment data in a modern clinic.

What if your next diabetes appointment started before you even walked in—an algorithm already having reviewed your CGM data, flagged risks, and drafted a care plan? That’s not science fiction. It’s the emerging reality of AI-powered workflows for diabetes care, where intelligent systems work behind the scenes to support clinicians …

Read More »

AI for Insulin Management: Letting Algorithms Help—Without Handing Over the Wheel

AI-driven diabetes tools including CGM sensor, smartphone displaying glucose data, and insulin pump with a digital brain hologram representing AI analysis.

Artificial intelligence (AI) is transforming many aspects of diabetes care, and smart insulin management powered by AI is quickly becoming one of its most promising innovations. Tools that read continuous glucose monitor (CGM) data and suggest insulin changes are rapidly entering clinical use. But while these tools are powerful, they …

Read More »

GLP‑1s in Menopause: Using Incretins to Protect Cardiometabolic Health in Midlife

Middle-aged woman smiling in a medical office, holding a medication bottle to represent GLP‑1 therapy during menopause.

Menopause marks a major transition in a woman’s life, defined not only by the end of menstrual cycles but also by profound hormonal and metabolic changes. One often under‑recognized shift is the acceleration of cardiometabolic risk. Women in midlife frequently experience increased central adiposity, changes in glucose regulation, rising blood …

Read More »

Continuous Ketone Monitoring: Can We Finally Get Ahead of DKA?

Continuous ketone monitor on a patient’s abdomen showing ketone levels, with a smartphone displaying rising ketone alerts and a virtual doctor consult in the background.

Diabetic ketoacidosis (DKA) continues to be one of the most dangerous acute complications faced by people with diabetes, particularly those on insulin or SGLT2 inhibitors. While traditional approaches rely on intermittent blood ketone checks, a new frontier is emerging—continuous ketone monitoring for DKA prevention. This article explores how this technology …

Read More »

AI Decision Support for CGM and Insulin: How to Use It Without Losing Clinical Judgment

Clinician desk with CGM device, insulin tools, and smartphone showing AI insulin adjustment recommendation

AI decision support in diabetes care is reshaping how clinicians manage continuous glucose monitoring (CGM) and insulin dosing. These tools deliver quick data-driven recommendations, raising key questions: How do we preserve clinical judgment? Where does AI end and provider expertise begin? This article explains how to safely evaluate and use …

Read More »

Sleep as a Vital Sign: Putting the ADA 2026 Diabetes Sleep Guidelines Into Practice

Sleep and diabetes management tools including glucose monitor, insulin, CPAP machine, and sleep checklist by bedside, representing ADA 2026 diabetes sleep guidelines.

With the release of the ADA 2026 diabetes sleep guidelines, the American Diabetes Association has officially elevated sleep and circadian rhythm health to core pillars of diabetes care—right alongside nutrition, physical activity, and medication. These new standards mark a significant shift toward more holistic and behavioral-focused approaches to managing diabetes. …

Read More »

Choosing the Right Tech: A Clinician’s Guide to Today’s Diabetes Devices

A selection of diabetes devices including CGMs, insulin pumps, and a smartphone displaying glucose data, arranged on a clinician’s desk.

With diabetes technology evolving rapidly, clinicians face more choices than ever before. From continuous glucose monitors (CGMs) to insulin pumps and patch devices, today’s tools can transform diabetes care—but only when matched to the right patient. This article provides a comprehensive diabetes technology comparison, helping you understand each option’s features, …

Read More »

Once‑Weekly Insulin in the Real World: Who It Helps and How to Use It

A once‑weekly insulin pen placed on a calendar marked for Thursday, with insulin vials and pills in the background, illustrating simplified diabetes treatment.

Imagine reducing your patients’ insulin injections from 365 a year to just 52. That’s the promise of once‑weekly insulin — a next-generation option designed to simplify treatment, enhance adherence, and improve patient outcomes. While this innovation is gaining traction, many healthcare providers still have questions about when and how to …

Read More »

Catching Type 1 Earlier: How Autoantibody Screening Is Changing the Playbook

Conceptual image showing type 1 diabetes autoantibody screening with glucose monitor, test tube, pancreas model, and antibody vials labeled GADA, IA-2A, and ZnT8A.

Type 1 diabetes doesn’t have to be a surprise. Thanks to type 1 diabetes autoantibody screening, clinicians can now identify individuals at high risk before symptoms even appear. This early detection opens doors for proactive monitoring, patient education, and potentially delaying or preventing full-blown disease. But who should be screened? …

Read More »

Preventing Diabetes Complications After Hospital Discharge: A Checklist for Clinicians

Diabetes discharge checklist with glucose monitor, insulin, stethoscope, and calendar on a clinician's desk.

Hospital discharge marks a critical juncture in the care of people with diabetes. It’s a period often riddled with risk—confusion about medications, fluctuating blood sugar levels, and a lack of follow-up can easily derail recovery. As clinicians, how can we improve post-discharge outcomes and reduce readmissions? This practical checklist offers …

Read More »